Dr. Richard Todd Frederick, MD

Dr. Frederick practices at California Pacific Medical Center - B.H. Cancer Care Center-Buchanan St - HOPD in San Francisco, California.

Dr. Frederick's NPI, 1720009160, was assigned on July 21, 2006. Dr. Frederick graduated from New York Medical College in 1998. Dr. Frederick holds California license A71441.

Dr. Frederick's primary practice is California Pacific Medical Center - B.H. Cancer Care Center-Buchanan St - HOPD, at 2333 Buchanan St, San Francisco, CA 94115.

Dr. Frederick's primary practice is California Pacific Medical Center - B.H. Cancer Care Center-Buchanan St - HOPD in San Francisco, California. Dr. Frederick is also affiliated with California Pacific Medical Center Van Ness Campus. The medical group on file is Palo Alto Foundation Medical Group. Dmand AI also links Dr. Frederick to 4 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Frederick practices, 7 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Frederick's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. Frederick is board certified in gastroenterology by the American Board of Internal Medicine. Dmand AI has Dr. Frederick's licenses on file in 2 states: California and Nevada.

Dmand AI lists bile duct problems, cirrhosis of the liver, colonoscopy, fatty liver, hepatitis c and upper GI endoscopy among the conditions Dr. Frederick treats.

CMS data shows 990 Medicare services from Dr. Frederick across 8 procedure codes in 2024, for 461 Medicare patients. Medicare paid $115,863 for them.

CMS counts 461 Medicare patients who saw Dr. Frederick in 2024. The largest group is 65 to 74, with 256 patients. 74% of them have high blood pressure, and 64% have high cholesterol. 39% are also on Medicaid. Their average risk score is 2.36, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Frederick's median patient age at 64, with 46% women.

In 2024, Dr. Frederick wrote 1,898 Medicare Part D claims for 242 patients. 74% of them were for generic drugs. CMS names the drug for 1,658 of them, across 30 drugs with 11 or more claims each, at $1,327,491 in total drug cost. In 2023, CMS named 1,371 claims across 23 drugs.

Dr. Frederick accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Frederick as offering telehealth. CMS counts 15 procedures of upper gastrointestinal (gi) endoscopy for acid reflux by Dr. Frederick, more than 46% of the clinicians it reports for that procedure.

Colonoscopy: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 16 papers to Dr. Frederick, published from 2007 to 2024. 2023 was the busiest year, with 3. The most frequent topics are Hepatic Encephalopathy, Hepatorenal Syndrome and Liver Cirrhosis. Dr. Frederick has published most often in Clin Gastroenterol Hepatol. Dr. Frederick's most frequent co-authors are Raymond A. Rubin, MD, Ethan Michael Weinberg and Natalie Bzowej, MD.

CMS Open Payments shows 139 general payments to Dr. Frederick from 16 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 56% of the total. Mallinckrodt Hospital Products Inc. paid the most, $65,843. It also lists 2 research payments totaling $273 in 2016.

Dr. Frederick graduated from New York Medical College in 1998. Dr. Frederick is a member of AOA, ACG and AGA.

Dr. Frederick is in network with 14 carriers, including Aetna, United Healthcare and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.